A Modular, Open-label, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of EP0031 in Patients With Advanced RET-altered Malignancies

14494EP0031-101OpenA Modular, Open-label, Phase I/II Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of EP0031 in Patients With Advanced RET-altered MalignanciesNCT05443126IndustrialAdultTreatmentI/IIOtherLiu, StephenGeorgetown University Medical Center : Jeanette Crawford; Lombardi Comprehensive Cancer Center : Jeanette CrawfordThoracic/CNS/H&N/ThyroidOncology GroupLombardi Comprehensive Cancer Center (LCCC); Oncology PFS6888Jeanette CrawfordJeanette Crawford+1 202-687-0893crawfojg@georgetown.eduResearch Nursing Coordinator 2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>